Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Condition:   Ulcerative Colitis Intervention:   Drug: ABX464 Sponsor:   Abivax S.A. Not yet recruiting

Source: ClinicalTrials.gov - July 17, 2019 Category: Research Source Type: clinical trials